nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—Dactinomycin—uterine cancer	0.108	0.163	CbGbCtD
Telmisartan—ABCC2—Carboplatin—uterine cancer	0.0802	0.121	CbGbCtD
Telmisartan—ABCG2—Carboplatin—uterine cancer	0.0725	0.11	CbGbCtD
Telmisartan—ABCC2—Etoposide—uterine cancer	0.0674	0.102	CbGbCtD
Telmisartan—ABCG2—Etoposide—uterine cancer	0.0609	0.092	CbGbCtD
Telmisartan—CYP2C19—Progesterone—uterine cancer	0.0608	0.0918	CbGbCtD
Telmisartan—ABCB1—Progesterone—uterine cancer	0.0491	0.0741	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—uterine cancer	0.0459	0.0694	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—uterine cancer	0.0415	0.0627	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—uterine cancer	0.0389	0.0588	CbGbCtD
Telmisartan—ABCB1—Etoposide—uterine cancer	0.022	0.0332	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—uterine cancer	0.015	0.0226	CbGbCtD
Telmisartan—AGTR1—artery—uterine cancer	0.00571	0.0907	CbGeAlD
Telmisartan—PPARG—artery—uterine cancer	0.0047	0.0746	CbGeAlD
Telmisartan—PPARG—Teniposide—Etoposide—uterine cancer	0.00374	1	CbGdCrCtD
Telmisartan—AGTR1—myometrium—uterine cancer	0.00276	0.0438	CbGeAlD
Telmisartan—SLCO1B3—vagina—uterine cancer	0.0024	0.0381	CbGeAlD
Telmisartan—AGTR1—epithelium—uterine cancer	0.00217	0.0344	CbGeAlD
Telmisartan—AGTR1—uterine cervix—uterine cancer	0.00215	0.0341	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—uterine cancer	0.00209	0.0331	CbGeAlD
Telmisartan—AGTR1—decidua—uterine cancer	0.00205	0.0325	CbGeAlD
Telmisartan—AGTR1—renal system—uterine cancer	0.00201	0.0319	CbGeAlD
Telmisartan—PPARG—epithelium—uterine cancer	0.00178	0.0283	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—uterine cancer	0.00172	0.0272	CbGeAlD
Telmisartan—PPARG—decidua—uterine cancer	0.00168	0.0267	CbGeAlD
Telmisartan—PPARG—renal system—uterine cancer	0.00165	0.0262	CbGeAlD
Telmisartan—AGTR1—female reproductive system—uterine cancer	0.00161	0.0255	CbGeAlD
Telmisartan—PPARG—mammalian vulva—uterine cancer	0.00155	0.0245	CbGeAlD
Telmisartan—PPARG—uterus—uterine cancer	0.00147	0.0234	CbGeAlD
Telmisartan—AGTR1—vagina—uterine cancer	0.00146	0.0231	CbGeAlD
Telmisartan—ABCG2—myometrium—uterine cancer	0.00145	0.0231	CbGeAlD
Telmisartan—ABCC2—renal system—uterine cancer	0.00145	0.023	CbGeAlD
Telmisartan—PPARG—female reproductive system—uterine cancer	0.00132	0.021	CbGeAlD
Telmisartan—PPARG—female gonad—uterine cancer	0.0012	0.0191	CbGeAlD
Telmisartan—PPARG—vagina—uterine cancer	0.0012	0.019	CbGeAlD
Telmisartan—ABCC2—female reproductive system—uterine cancer	0.00116	0.0185	CbGeAlD
Telmisartan—ABCG2—uterine cervix—uterine cancer	0.00113	0.018	CbGeAlD
Telmisartan—ABCG2—decidua—uterine cancer	0.00108	0.0171	CbGeAlD
Telmisartan—ABCG2—endometrium—uterine cancer	0.00102	0.0163	CbGeAlD
Telmisartan—ABCG2—mammalian vulva—uterine cancer	0.00099	0.0157	CbGeAlD
Telmisartan—ABCG2—uterus—uterine cancer	0.000944	0.015	CbGeAlD
Telmisartan—AGTR1—lymph node—uterine cancer	0.000941	0.0149	CbGeAlD
Telmisartan—CYP2C19—vagina—uterine cancer	0.000904	0.0143	CbGeAlD
Telmisartan—PPARG—lymph node—uterine cancer	0.000774	0.0123	CbGeAlD
Telmisartan—ABCG2—female gonad—uterine cancer	0.000772	0.0122	CbGeAlD
Telmisartan—ABCG2—vagina—uterine cancer	0.000767	0.0122	CbGeAlD
Telmisartan—ABCB1—myometrium—uterine cancer	0.000717	0.0114	CbGeAlD
Telmisartan—ABCC2—lymph node—uterine cancer	0.00068	0.0108	CbGeAlD
Telmisartan—ABCB1—epithelium—uterine cancer	0.000563	0.00894	CbGeAlD
Telmisartan—ABCB1—uterine cervix—uterine cancer	0.000558	0.00886	CbGeAlD
Telmisartan—ABCB1—decidua—uterine cancer	0.000532	0.00844	CbGeAlD
Telmisartan—ABCB1—renal system—uterine cancer	0.000522	0.00829	CbGeAlD
Telmisartan—ABCB1—endometrium—uterine cancer	0.000505	0.00801	CbGeAlD
Telmisartan—ABCG2—lymph node—uterine cancer	0.000496	0.00787	CbGeAlD
Telmisartan—ABCB1—mammalian vulva—uterine cancer	0.000488	0.00775	CbGeAlD
Telmisartan—ABCB1—uterus—uterine cancer	0.000465	0.00738	CbGeAlD
Telmisartan—ABCB1—female reproductive system—uterine cancer	0.000418	0.00664	CbGeAlD
Telmisartan—ABCB1—female gonad—uterine cancer	0.000381	0.00604	CbGeAlD
Telmisartan—ABCB1—vagina—uterine cancer	0.000378	0.006	CbGeAlD
Telmisartan—ABCB1—lymph node—uterine cancer	0.000245	0.00388	CbGeAlD
Telmisartan—Migraine—Doxorubicin—uterine cancer	0.000215	0.000835	CcSEcCtD
Telmisartan—Hypokalaemia—Epirubicin—uterine cancer	0.000215	0.000835	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000214	0.000833	CcSEcCtD
Telmisartan—Discomfort—Etoposide—uterine cancer	0.000213	0.000829	CcSEcCtD
Telmisartan—Breast disorder—Epirubicin—uterine cancer	0.000213	0.000829	CcSEcCtD
Telmisartan—Face oedema—Doxorubicin—uterine cancer	0.000211	0.000819	CcSEcCtD
Telmisartan—Hypersensitivity—Dactinomycin—uterine cancer	0.00021	0.000819	CcSEcCtD
Telmisartan—Gastritis—Epirubicin—uterine cancer	0.000209	0.000812	CcSEcCtD
Telmisartan—Muscular weakness—Epirubicin—uterine cancer	0.000208	0.000809	CcSEcCtD
Telmisartan—Anaphylactic shock—Etoposide—uterine cancer	0.000207	0.000804	CcSEcCtD
Telmisartan—Infection—Etoposide—uterine cancer	0.000205	0.000799	CcSEcCtD
Telmisartan—Abdominal distension—Epirubicin—uterine cancer	0.000205	0.000798	CcSEcCtD
Telmisartan—Asthenia—Dactinomycin—uterine cancer	0.000205	0.000797	CcSEcCtD
Telmisartan—Blood creatinine increased—Doxorubicin—uterine cancer	0.000204	0.000795	CcSEcCtD
Telmisartan—Asthma—Epirubicin—uterine cancer	0.000204	0.000793	CcSEcCtD
Telmisartan—Thrombocytopenia—Etoposide—uterine cancer	0.000202	0.000788	CcSEcCtD
Telmisartan—Tachycardia—Etoposide—uterine cancer	0.000202	0.000785	CcSEcCtD
Telmisartan—Eosinophilia—Epirubicin—uterine cancer	0.000202	0.000785	CcSEcCtD
Telmisartan—Skin disorder—Etoposide—uterine cancer	0.000201	0.000781	CcSEcCtD
Telmisartan—Dry skin—Doxorubicin—uterine cancer	0.0002	0.000778	CcSEcCtD
Telmisartan—Hyperhidrosis—Etoposide—uterine cancer	0.0002	0.000778	CcSEcCtD
Telmisartan—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000199	0.000775	CcSEcCtD
Telmisartan—Hypokalaemia—Doxorubicin—uterine cancer	0.000199	0.000772	CcSEcCtD
Telmisartan—Angina pectoris—Epirubicin—uterine cancer	0.000198	0.000772	CcSEcCtD
Telmisartan—Breast disorder—Doxorubicin—uterine cancer	0.000197	0.000767	CcSEcCtD
Telmisartan—Anorexia—Etoposide—uterine cancer	0.000197	0.000767	CcSEcCtD
Telmisartan—Bronchitis—Epirubicin—uterine cancer	0.000196	0.000762	CcSEcCtD
Telmisartan—Diarrhoea—Dactinomycin—uterine cancer	0.000195	0.00076	CcSEcCtD
Telmisartan—Hypotension—Etoposide—uterine cancer	0.000193	0.000752	CcSEcCtD
Telmisartan—Gastritis—Doxorubicin—uterine cancer	0.000193	0.000751	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—uterine cancer	0.000192	0.000749	CcSEcCtD
Telmisartan—Dysuria—Epirubicin—uterine cancer	0.000191	0.000741	CcSEcCtD
Telmisartan—Abdominal distension—Doxorubicin—uterine cancer	0.00019	0.000739	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000189	0.000737	CcSEcCtD
Telmisartan—Asthma—Doxorubicin—uterine cancer	0.000189	0.000734	CcSEcCtD
Telmisartan—Pollakiuria—Epirubicin—uterine cancer	0.000188	0.000732	CcSEcCtD
Telmisartan—Eosinophilia—Doxorubicin—uterine cancer	0.000187	0.000726	CcSEcCtD
Telmisartan—Paraesthesia—Etoposide—uterine cancer	0.000186	0.000722	CcSEcCtD
Telmisartan—Dyspnoea—Etoposide—uterine cancer	0.000184	0.000717	CcSEcCtD
Telmisartan—Somnolence—Etoposide—uterine cancer	0.000184	0.000715	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—uterine cancer	0.000184	0.000715	CcSEcCtD
Telmisartan—Pneumonia—Epirubicin—uterine cancer	0.000183	0.000711	CcSEcCtD
Telmisartan—Infestation NOS—Epirubicin—uterine cancer	0.000182	0.000707	CcSEcCtD
Telmisartan—Infestation—Epirubicin—uterine cancer	0.000182	0.000707	CcSEcCtD
Telmisartan—Vomiting—Dactinomycin—uterine cancer	0.000182	0.000707	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—uterine cancer	0.000181	0.000706	CcSEcCtD
Telmisartan—Rash—Dactinomycin—uterine cancer	0.00018	0.000701	CcSEcCtD
Telmisartan—Decreased appetite—Etoposide—uterine cancer	0.00018	0.000699	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—uterine cancer	0.000179	0.000695	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000178	0.000694	CcSEcCtD
Telmisartan—Fatigue—Etoposide—uterine cancer	0.000178	0.000693	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—uterine cancer	0.000178	0.000693	CcSEcCtD
Telmisartan—Pain—Etoposide—uterine cancer	0.000177	0.000688	CcSEcCtD
Telmisartan—Constipation—Etoposide—uterine cancer	0.000177	0.000688	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—uterine cancer	0.000177	0.000687	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—uterine cancer	0.000177	0.000687	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—uterine cancer	0.000176	0.000686	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000175	0.000682	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—uterine cancer	0.000174	0.000678	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—uterine cancer	0.000173	0.000674	CcSEcCtD
Telmisartan—Hepatobiliary disease—Epirubicin—uterine cancer	0.000172	0.000669	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—uterine cancer	0.000171	0.000667	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—uterine cancer	0.00017	0.000663	CcSEcCtD
Telmisartan—Feeling abnormal—Etoposide—uterine cancer	0.00017	0.000663	CcSEcCtD
Telmisartan—Nausea—Dactinomycin—uterine cancer	0.00017	0.00066	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—uterine cancer	0.000169	0.000658	CcSEcCtD
Telmisartan—Gastrointestinal pain—Etoposide—uterine cancer	0.000169	0.000658	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—uterine cancer	0.000168	0.000654	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—uterine cancer	0.000168	0.000654	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—uterine cancer	0.000166	0.000646	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—uterine cancer	0.000165	0.000643	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000165	0.000641	CcSEcCtD
Telmisartan—Urticaria—Etoposide—uterine cancer	0.000164	0.000639	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—uterine cancer	0.000163	0.000636	CcSEcCtD
Telmisartan—Body temperature increased—Etoposide—uterine cancer	0.000163	0.000636	CcSEcCtD
Telmisartan—Abdominal pain—Etoposide—uterine cancer	0.000163	0.000636	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—uterine cancer	0.000163	0.000636	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—uterine cancer	0.000163	0.000636	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—uterine cancer	0.000162	0.000631	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—uterine cancer	0.000162	0.00063	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—uterine cancer	0.000161	0.000627	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—uterine cancer	0.000161	0.000625	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—uterine cancer	0.00016	0.000624	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—uterine cancer	0.00016	0.000624	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—uterine cancer	0.00016	0.000622	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000159	0.000619	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—uterine cancer	0.000159	0.000617	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—uterine cancer	0.000158	0.000614	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—uterine cancer	0.000157	0.000612	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—uterine cancer	0.000154	0.000598	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—uterine cancer	0.000152	0.000593	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—uterine cancer	0.000152	0.000593	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—uterine cancer	0.000152	0.000592	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—uterine cancer	0.000151	0.000589	CcSEcCtD
Telmisartan—Flushing—Epirubicin—uterine cancer	0.000151	0.000589	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—uterine cancer	0.000151	0.000589	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—uterine cancer	0.00015	0.000584	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—uterine cancer	0.00015	0.000583	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—uterine cancer	0.000149	0.00058	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—uterine cancer	0.000149	0.000578	CcSEcCtD
Telmisartan—Asthenia—Etoposide—uterine cancer	0.000148	0.000577	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—uterine cancer	0.000148	0.000577	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—uterine cancer	0.000148	0.000576	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—uterine cancer	0.000148	0.000576	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—uterine cancer	0.000147	0.000573	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—uterine cancer	0.000147	0.000572	CcSEcCtD
Telmisartan—Chills—Epirubicin—uterine cancer	0.000146	0.000569	CcSEcCtD
Telmisartan—Pruritus—Etoposide—uterine cancer	0.000146	0.000569	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—uterine cancer	0.000146	0.000567	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—uterine cancer	0.000145	0.000566	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—uterine cancer	0.000143	0.000556	CcSEcCtD
Telmisartan—Erythema—Epirubicin—uterine cancer	0.000142	0.000552	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—uterine cancer	0.000142	0.000552	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—uterine cancer	0.000141	0.00055	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—uterine cancer	0.000141	0.000549	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—uterine cancer	0.000141	0.000547	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—uterine cancer	0.00014	0.000545	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—uterine cancer	0.00014	0.000545	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—uterine cancer	0.00014	0.000544	CcSEcCtD
Telmisartan—Tension—Epirubicin—uterine cancer	0.000139	0.000542	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—uterine cancer	0.000139	0.000541	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—uterine cancer	0.000138	0.000537	CcSEcCtD
Telmisartan—Back pain—Epirubicin—uterine cancer	0.000137	0.000534	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—uterine cancer	0.000137	0.000533	CcSEcCtD
Telmisartan—Dizziness—Etoposide—uterine cancer	0.000137	0.000532	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—uterine cancer	0.000136	0.000531	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—uterine cancer	0.000136	0.00053	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—uterine cancer	0.000136	0.000529	CcSEcCtD
Telmisartan—Chills—Doxorubicin—uterine cancer	0.000135	0.000527	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—uterine cancer	0.000135	0.000525	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—uterine cancer	0.000132	0.000514	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—uterine cancer	0.000132	0.000513	CcSEcCtD
Telmisartan—Vomiting—Etoposide—uterine cancer	0.000131	0.000511	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—uterine cancer	0.000131	0.000511	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—uterine cancer	0.000131	0.000511	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—uterine cancer	0.000131	0.000511	CcSEcCtD
Telmisartan—Rash—Etoposide—uterine cancer	0.00013	0.000507	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—uterine cancer	0.00013	0.000507	CcSEcCtD
Telmisartan—Headache—Etoposide—uterine cancer	0.000129	0.000504	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—uterine cancer	0.000129	0.000504	CcSEcCtD
Telmisartan—Tension—Doxorubicin—uterine cancer	0.000129	0.000502	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—uterine cancer	0.000129	0.000501	CcSEcCtD
Telmisartan—Malaise—Epirubicin—uterine cancer	0.000128	0.000498	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—uterine cancer	0.000128	0.000496	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—uterine cancer	0.000128	0.000496	CcSEcCtD
Telmisartan—Syncope—Epirubicin—uterine cancer	0.000127	0.000495	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—uterine cancer	0.000127	0.000494	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—uterine cancer	0.000126	0.000491	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—uterine cancer	0.000125	0.000488	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—uterine cancer	0.000125	0.000486	CcSEcCtD
Telmisartan—Cough—Epirubicin—uterine cancer	0.000124	0.000482	CcSEcCtD
Telmisartan—Nausea—Etoposide—uterine cancer	0.000123	0.000478	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—uterine cancer	0.000123	0.000477	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—uterine cancer	0.000122	0.000474	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—uterine cancer	0.000121	0.000472	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—uterine cancer	0.000121	0.00047	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—uterine cancer	0.000121	0.00047	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—uterine cancer	0.000121	0.00047	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—uterine cancer	0.00012	0.000469	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00012	0.000467	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—uterine cancer	0.000119	0.000465	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—uterine cancer	0.000118	0.000461	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—uterine cancer	0.000118	0.00046	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—uterine cancer	0.000118	0.000459	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—uterine cancer	0.000118	0.000458	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—uterine cancer	0.000116	0.000452	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—uterine cancer	0.000116	0.000451	CcSEcCtD
Telmisartan—Oedema—Epirubicin—uterine cancer	0.000116	0.000451	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—uterine cancer	0.000115	0.000449	CcSEcCtD
Telmisartan—Infection—Epirubicin—uterine cancer	0.000115	0.000448	CcSEcCtD
Telmisartan—Cough—Doxorubicin—uterine cancer	0.000115	0.000446	CcSEcCtD
Telmisartan—Shock—Epirubicin—uterine cancer	0.000114	0.000444	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—uterine cancer	0.000114	0.000442	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—uterine cancer	0.000113	0.000441	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—uterine cancer	0.000113	0.000441	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—uterine cancer	0.000113	0.00044	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—uterine cancer	0.000113	0.000438	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—uterine cancer	0.000112	0.000436	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—uterine cancer	0.000112	0.000435	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—uterine cancer	0.000112	0.000435	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—uterine cancer	0.000112	0.000435	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—uterine cancer	0.000111	0.000434	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000111	0.000432	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—uterine cancer	0.00011	0.00043	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—uterine cancer	0.00011	0.00043	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—uterine cancer	0.000109	0.000426	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—uterine cancer	0.000108	0.000421	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—uterine cancer	0.000107	0.000417	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—uterine cancer	0.000107	0.000417	CcSEcCtD
Telmisartan—Infection—Doxorubicin—uterine cancer	0.000107	0.000414	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000106	0.000411	CcSEcCtD
Telmisartan—Shock—Doxorubicin—uterine cancer	0.000105	0.00041	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—uterine cancer	0.000105	0.000409	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—uterine cancer	0.000105	0.000408	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—uterine cancer	0.000105	0.000408	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—uterine cancer	0.000105	0.000407	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—uterine cancer	0.000104	0.000405	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—uterine cancer	0.000104	0.000405	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000104	0.000403	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—uterine cancer	0.000103	0.000402	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—uterine cancer	0.000103	0.000401	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—uterine cancer	0.000102	0.000398	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—uterine cancer	0.000102	0.000397	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—uterine cancer	0.000101	0.000392	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—uterine cancer	0.0001	0.00039	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.0001	0.000389	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—uterine cancer	9.99e-05	0.000389	CcSEcCtD
Telmisartan—Pain—Epirubicin—uterine cancer	9.91e-05	0.000386	CcSEcCtD
Telmisartan—Constipation—Epirubicin—uterine cancer	9.91e-05	0.000386	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.77e-05	0.00038	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—uterine cancer	9.7e-05	0.000377	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—uterine cancer	9.63e-05	0.000375	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—uterine cancer	9.56e-05	0.000372	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—uterine cancer	9.55e-05	0.000372	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—uterine cancer	9.53e-05	0.000371	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—uterine cancer	9.47e-05	0.000369	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—uterine cancer	9.44e-05	0.000367	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—uterine cancer	9.32e-05	0.000363	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.26e-05	0.00036	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—uterine cancer	9.24e-05	0.00036	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—uterine cancer	9.2e-05	0.000358	CcSEcCtD
Telmisartan—Pain—Doxorubicin—uterine cancer	9.17e-05	0.000357	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—uterine cancer	9.17e-05	0.000357	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—uterine cancer	9.16e-05	0.000356	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—uterine cancer	9.16e-05	0.000356	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—uterine cancer	8.83e-05	0.000344	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—uterine cancer	8.77e-05	0.000341	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.58e-05	0.00612	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.58e-05	0.00612	CbGpPWpGaD
Telmisartan—Hypersensitivity—Epirubicin—uterine cancer	8.54e-05	0.000332	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—uterine cancer	8.52e-05	0.000331	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—uterine cancer	8.47e-05	0.00033	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—uterine cancer	8.47e-05	0.00033	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—uterine cancer	8.46e-05	0.00603	CbGpPWpGaD
Telmisartan—Asthenia—Epirubicin—uterine cancer	8.31e-05	0.000323	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN1B—uterine cancer	8.2e-05	0.00585	CbGpPWpGaD
Telmisartan—Pruritus—Epirubicin—uterine cancer	8.2e-05	0.000319	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	8.17e-05	0.00583	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.16e-05	0.00582	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—uterine cancer	7.93e-05	0.00566	CbGpPWpGaD
Telmisartan—Diarrhoea—Epirubicin—uterine cancer	7.93e-05	0.000308	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—uterine cancer	7.9e-05	0.000307	CcSEcCtD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.87e-05	0.00562	CbGpPWpGaD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.77e-05	0.00554	CbGpPWpGaD
Telmisartan—Asthenia—Doxorubicin—uterine cancer	7.69e-05	0.000299	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—uterine cancer	7.66e-05	0.000298	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	7.6e-05	0.00542	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	7.59e-05	0.00541	CbGpPWpGaD
Telmisartan—Pruritus—Doxorubicin—uterine cancer	7.58e-05	0.000295	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—uterine cancer	7.37e-05	0.000287	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—uterine cancer	7.34e-05	0.000285	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.32e-05	0.00522	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.32e-05	0.00522	CbGpPWpGaD
Telmisartan—Rash—Epirubicin—uterine cancer	7.31e-05	0.000284	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—uterine cancer	7.3e-05	0.00521	CbGpPWpGaD
Telmisartan—Dermatitis—Epirubicin—uterine cancer	7.3e-05	0.000284	CcSEcCtD
Telmisartan—Headache—Epirubicin—uterine cancer	7.26e-05	0.000282	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—EP300—uterine cancer	7.2e-05	0.00514	CbGpPWpGaD
Telmisartan—Dizziness—Doxorubicin—uterine cancer	7.09e-05	0.000276	CcSEcCtD
Telmisartan—Nausea—Epirubicin—uterine cancer	6.88e-05	0.000268	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—EP300—uterine cancer	6.87e-05	0.0049	CbGpPWpGaD
Telmisartan—Vomiting—Doxorubicin—uterine cancer	6.82e-05	0.000265	CcSEcCtD
Telmisartan—Rash—Doxorubicin—uterine cancer	6.76e-05	0.000263	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—uterine cancer	6.75e-05	0.000263	CcSEcCtD
Telmisartan—Headache—Doxorubicin—uterine cancer	6.72e-05	0.000261	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—HNF1B—uterine cancer	6.68e-05	0.00477	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	6.54e-05	0.00467	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PHF1—uterine cancer	6.51e-05	0.00464	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.38e-05	0.00455	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—uterine cancer	6.37e-05	0.000248	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	6.37e-05	0.00454	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.3e-05	0.00449	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL2—uterine cancer	6.12e-05	0.00437	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.84e-05	0.00416	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	5.83e-05	0.00416	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	5.64e-05	0.00402	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	5.58e-05	0.00398	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CHD4—uterine cancer	5.53e-05	0.00395	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.38e-05	0.00383	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NDUFB11—uterine cancer	5.29e-05	0.00377	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SRD5A2—uterine cancer	5.29e-05	0.00377	CbGpPWpGaD
Telmisartan—PPARG—Wnt Signaling Pathway Netpath—AKT1—uterine cancer	5.27e-05	0.00376	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	5.25e-05	0.00375	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—PIK3CA—uterine cancer	5.14e-05	0.00367	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.14e-05	0.00366	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.08e-05	0.00362	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	4.97e-05	0.00355	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	4.9e-05	0.00349	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.85e-05	0.00346	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—uterine cancer	4.84e-05	0.00345	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—PGR—uterine cancer	4.8e-05	0.00342	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—EP300—uterine cancer	4.79e-05	0.00341	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	4.68e-05	0.00334	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SUZ12—uterine cancer	4.64e-05	0.00331	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	4.61e-05	0.00329	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	4.55e-05	0.00324	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SRD5A2—uterine cancer	4.51e-05	0.00322	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NDUFB11—uterine cancer	4.51e-05	0.00322	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—CTNNB1—uterine cancer	4.5e-05	0.00321	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.38e-05	0.00313	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.29e-05	0.00306	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—ESR2—uterine cancer	4.22e-05	0.00301	CbGpPWpGaD
Telmisartan—PPARG—SREBP signalling—AKT1—uterine cancer	4.2e-05	0.003	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.14e-05	0.00295	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	4.11e-05	0.00293	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	4.1e-05	0.00293	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.09e-05	0.00292	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKR1B10—uterine cancer	3.94e-05	0.00281	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—STAR—uterine cancer	3.82e-05	0.00273	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKR1B1—uterine cancer	3.82e-05	0.00273	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.78e-05	0.00269	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.62e-05	0.00258	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	3.52e-05	0.00251	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—CDKN2B—uterine cancer	3.44e-05	0.00245	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.39e-05	0.00242	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.35e-05	0.00239	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.34e-05	0.00239	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SRD5A2—uterine cancer	3.29e-05	0.00235	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NDUFB11—uterine cancer	3.29e-05	0.00235	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RNF43—uterine cancer	3.27e-05	0.00233	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—STAR—uterine cancer	3.26e-05	0.00233	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKR1B1—uterine cancer	3.26e-05	0.00233	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	3.25e-05	0.00232	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	3.23e-05	0.0023	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.22e-05	0.0023	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	3.17e-05	0.00226	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—SMAD3—uterine cancer	3.14e-05	0.00224	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL2—uterine cancer	3.13e-05	0.00223	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—PIK3CA—uterine cancer	3.11e-05	0.00222	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—PTEN—uterine cancer	3.1e-05	0.00221	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.04e-05	0.00217	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	3.03e-05	0.00216	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POLD1—uterine cancer	3e-05	0.00214	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—INHBA—uterine cancer	2.99e-05	0.00213	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.96e-05	0.00211	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.96e-05	0.00211	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—EP300—uterine cancer	2.95e-05	0.00211	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—SMAD3—uterine cancer	2.95e-05	0.00211	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.87e-05	0.00204	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.84e-05	0.00202	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKR1C1—uterine cancer	2.81e-05	0.002	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	2.78e-05	0.00198	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.75e-05	0.00196	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.73e-05	0.00195	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.69e-05	0.00192	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKR1C1—uterine cancer	2.69e-05	0.00192	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	2.57e-05	0.00184	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	2.56e-05	0.00183	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POLD1—uterine cancer	2.56e-05	0.00183	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—RRM2—uterine cancer	2.5e-05	0.00178	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL8—uterine cancer	2.47e-05	0.00176	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—DCN—uterine cancer	2.43e-05	0.00173	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—uterine cancer	2.42e-05	0.00173	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKR1C1—uterine cancer	2.39e-05	0.00171	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1B1—uterine cancer	2.38e-05	0.0017	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—STAR—uterine cancer	2.38e-05	0.0017	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.33e-05	0.00166	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PGR—uterine cancer	2.31e-05	0.00165	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP11A1—uterine cancer	2.29e-05	0.00163	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—EZH2—uterine cancer	2.19e-05	0.00156	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.17e-05	0.00155	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKR1C3—uterine cancer	2.16e-05	0.00154	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RRM2—uterine cancer	2.13e-05	0.00152	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—uterine cancer	2.11e-05	0.00151	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—DCN—uterine cancer	2.07e-05	0.00148	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKR1C3—uterine cancer	2.07e-05	0.00148	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR2—uterine cancer	2.03e-05	0.00145	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.03e-05	0.00145	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PGR—uterine cancer	2.02e-05	0.00144	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP11A1—uterine cancer	1.95e-05	0.00139	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—YWHAE—uterine cancer	1.92e-05	0.00137	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POLD1—uterine cancer	1.87e-05	0.00133	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FBXW7—uterine cancer	1.84e-05	0.00132	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKR1C3—uterine cancer	1.84e-05	0.00131	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.82e-05	0.0013	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.82e-05	0.0013	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SRD5A2—uterine cancer	1.78e-05	0.00127	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NDUFB11—uterine cancer	1.78e-05	0.00127	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.77e-05	0.00126	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ERBB2—uterine cancer	1.77e-05	0.00126	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1C1—uterine cancer	1.75e-05	0.00124	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.72e-05	0.00122	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP19A1—uterine cancer	1.68e-05	0.0012	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—STK11—uterine cancer	1.68e-05	0.0012	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.67e-05	0.00119	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CDKN2B—uterine cancer	1.66e-05	0.00118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STK11—uterine cancer	1.61e-05	0.00115	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL2—uterine cancer	1.61e-05	0.00114	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.58e-05	0.00113	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RRM2—uterine cancer	1.56e-05	0.00111	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—uterine cancer	1.55e-05	0.0011	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SMAD3—uterine cancer	1.51e-05	0.00108	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—DCN—uterine cancer	1.51e-05	0.00108	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SOCS3—uterine cancer	1.51e-05	0.00108	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.51e-05	0.00107	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.49e-05	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN2B—uterine cancer	1.45e-05	0.00103	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EP300—uterine cancer	1.44e-05	0.00103	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—STK11—uterine cancer	1.44e-05	0.00102	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP19A1—uterine cancer	1.44e-05	0.00102	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP11A1—uterine cancer	1.42e-05	0.00101	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1R—uterine cancer	1.4e-05	0.001	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—uterine cancer	1.4e-05	0.000997	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.38e-05	0.000985	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—uterine cancer	1.36e-05	0.000972	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.35e-05	0.000961	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—uterine cancer	1.35e-05	0.00096	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKR1C3—uterine cancer	1.34e-05	0.000958	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMAD3—uterine cancer	1.32e-05	0.000941	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STAR—uterine cancer	1.32e-05	0.000939	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.32e-05	0.000939	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.31e-05	0.000931	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.3e-05	0.000929	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STAR—uterine cancer	1.29e-05	0.000917	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1B1—uterine cancer	1.29e-05	0.000917	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.29e-05	0.000917	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.27e-05	0.000907	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—uterine cancer	1.27e-05	0.000905	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—MTHFR—uterine cancer	1.26e-05	0.000902	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGFR2—uterine cancer	1.26e-05	0.000898	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR1—uterine cancer	1.23e-05	0.00088	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.21e-05	0.000865	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—uterine cancer	1.16e-05	0.000826	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.15e-05	0.00082	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.11e-05	0.000795	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—MTHFR—uterine cancer	1.08e-05	0.000769	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—uterine cancer	1.08e-05	0.000768	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP19A1—uterine cancer	1.05e-05	0.000747	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—STK11—uterine cancer	1.05e-05	0.000747	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POLD1—uterine cancer	1.03e-05	0.000737	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—uterine cancer	1.02e-05	0.000726	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POLD1—uterine cancer	1.01e-05	0.00072	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—uterine cancer	9.85e-06	0.000702	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.77e-06	0.000697	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.67e-06	0.00069	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.51e-06	0.000678	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL2—uterine cancer	9.48e-06	0.000676	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C1—uterine cancer	9.44e-06	0.000673	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.98e-06	0.00064	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—uterine cancer	8.87e-06	0.000632	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—uterine cancer	8.76e-06	0.000625	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—uterine cancer	8.7e-06	0.00062	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.68e-06	0.000619	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RRM2—uterine cancer	8.62e-06	0.000615	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RRM2—uterine cancer	8.41e-06	0.0006	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—DCN—uterine cancer	8.37e-06	0.000597	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—DCN—uterine cancer	8.17e-06	0.000582	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—uterine cancer	8.05e-06	0.000574	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—uterine cancer	7.91e-06	0.000564	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.88e-06	0.000562	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—MTHFR—uterine cancer	7.87e-06	0.000561	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP11A1—uterine cancer	7.69e-06	0.000549	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—uterine cancer	7.5e-06	0.000535	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—uterine cancer	7.45e-06	0.000531	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.44e-06	0.000531	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.33e-06	0.000523	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—uterine cancer	7.32e-06	0.000522	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKR1C3—uterine cancer	7.27e-06	0.000518	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—uterine cancer	7.24e-06	0.000516	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—uterine cancer	7.03e-06	0.000502	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—uterine cancer	6.92e-06	0.000493	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—uterine cancer	6.74e-06	0.000481	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—uterine cancer	6.71e-06	0.000478	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—uterine cancer	6.58e-06	0.000469	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—uterine cancer	6.43e-06	0.000458	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—uterine cancer	6.09e-06	0.000434	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—uterine cancer	6.01e-06	0.000429	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—uterine cancer	6e-06	0.000428	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STK11—uterine cancer	5.8e-06	0.000414	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.8e-06	0.000414	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—uterine cancer	5.72e-06	0.000408	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP19A1—uterine cancer	5.66e-06	0.000404	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STK11—uterine cancer	5.66e-06	0.000404	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.44e-06	0.000388	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.19e-06	0.00037	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—uterine cancer	5.18e-06	0.000369	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—uterine cancer	4.96e-06	0.000354	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—uterine cancer	4.76e-06	0.000339	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—uterine cancer	4.6e-06	0.000328	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—uterine cancer	4.45e-06	0.000317	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—uterine cancer	4.4e-06	0.000314	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—uterine cancer	4.38e-06	0.000312	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—MTHFR—uterine cancer	4.36e-06	0.000311	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—MTHFR—uterine cancer	4.25e-06	0.000303	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—uterine cancer	4.23e-06	0.000302	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—uterine cancer	4.17e-06	0.000298	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—uterine cancer	4.05e-06	0.000289	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—uterine cancer	3.89e-06	0.000277	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.84e-06	0.000274	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—uterine cancer	3.46e-06	0.000247	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—uterine cancer	3.09e-06	0.00022	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—uterine cancer	2.52e-06	0.00018	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—uterine cancer	2.42e-06	0.000173	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—uterine cancer	2.37e-06	0.000169	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—uterine cancer	2.31e-06	0.000165	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—uterine cancer	2.26e-06	0.000161	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.71e-06	0.000122	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—uterine cancer	1.67e-06	0.000119	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—uterine cancer	1.4e-06	9.96e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—uterine cancer	1.36e-06	9.72e-05	CbGpPWpGaD
